Actively Recruiting

Phase 4
Age: 0 - 1Year
All Genders
NCT04435834

Individual Cerebral Hemodynamic Oxygenation Relationships

Led by Matthew Borzage · Updated on 2024-09-03

30

Participants Needed

1

Research Sites

326 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a randomized controlled trial in patients who require clinical anesthesia. The main purpose of this study is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by two types of anesthesia: propofol or sevoflurane. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of propofol and sevoflurane are in clinical equipoise will be offered to have the anesthesia they will receive during their MRI randomized. All eligible subjects will be asked to provide informed consent before participating in the study.

CONDITIONS

Official Title

Individual Cerebral Hemodynamic Oxygenation Relationships

Who Can Participate

Age: 0 - 1Year
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who are scheduled for a clinically indicated MRI at the sponsor institution.
  • Patients who are able to tolerate an MRI.
  • Patients who require clinical anesthesia for their MRI.
  • Patients with conditions not believed to alter oxygen metabolism or blood flow in the brain, including but not limited to patients with orthopedic indications, undescended testicles, hernia repairs, term equivalent age scans.
  • Patients who have no medical conditions that make the use of propofol or sevoflurane better for their clinical outcome.
  • Patients between birth and up-to 1 year of age.
  • Patients with conditions known to alter oxygen metabolism or blood flow in the brain, e.g. traumatic brain injury, hypoxic ischemic encephalopathy, tumor.
Not Eligible

You will not qualify if you...

  • Patients with an MRI-incompatible device or implant (e.g. pacemakers, stents)
  • Preterm infants less than 25 weeks postmenstrual age (PMA) at the time of the scan.
  • Patients who are clinically too unstable to extend their MRI by up-to 10 minutes.
  • Patients who do not require clinical anesthesia.
  • Patients at risk for propofol infusion syndrome (known severe metabolic acidosis, hyperkalemia, lipemia, rhabdomyolysis, hepatomegaly, renal failure, ECG ST segment elevation, and/or cardiac failure)
  • Patients at risk for sevoflurane-based malignant hyperthermia (known ryanodine receptor mutations)
  • Patient at risk for sensitivity to volatile halogenated anesthetic agents (known congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval),
  • Patients with Perioperative Hyperkalemia (known neuromuscular disease, particularly Duchenne muscular dystrophy)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's Hospital Los Angeles

Los Angeles, California, United States, 90027

Actively Recruiting

Loading map...

Research Team

H

Hannah Wiseman

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here